| Active ingredient (INN) | Sunitinib |
|---|---|
| Brand names | Sandoz |
| ATC level 5 | L01EX01 |
| ATC level 4 | L01EX |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Sandoz Pty Ltd, Sun Pharma ANZ Pty Ltd, TEVA PHARMACEUTICALS USA, INC., Pfizer Australia Pty Ltd |
| Registrations on file | 22 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Sandoz | 12.5 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 25 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 50 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 37.5 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Arx | 12.5 mg | — | 🇦🇺 AU | — | Active |
| Sun | 12.5 mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| Arx | 25 mg | — | 🇦🇺 AU | — | Active |
| Sun | 50 mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| Sun | 37.5 mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| Sun | 25 mg | — | 🇦🇺 AU | Sun Pharma ANZ Pty Ltd | Active |
| Arx | 37.5 mg | — | 🇦🇺 AU | — | Active |
| Msn | 12.5 mg | — | 🇦🇺 AU | — | Active |
| Msn | 25 mg | — | 🇦🇺 AU | — | Active |
| Msn | 37.5 mg | — | 🇦🇺 AU | — | Active |
| Msn | 50 mg | — | 🇦🇺 AU | — | Active |